Tilo Senger

431 total citations
10 papers, 357 citations indexed

About

Tilo Senger is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Tilo Senger has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Immunology and 3 papers in Virology. Recurrent topics in Tilo Senger's work include Cervical Cancer and HPV Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Poxvirus research and outbreaks (2 papers). Tilo Senger is often cited by papers focused on Cervical Cancer and HPV Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Poxvirus research and outbreaks (2 papers). Tilo Senger collaborates with scholars based in Germany, Saudi Arabia and Austria. Tilo Senger's co-authors include Lutz Gissmann, Martin Müller, Gerard Manning, Nathaniel R. Landau, Bärbel Schröfelbauer, Carsten J. Kirschning, Corinna Klein, Ignacio G. Bravo, Norbert Mücke and Reinhard Kirnbauer and has published in prestigious journals such as PLoS ONE, Journal of Virology and British Journal of Cancer.

In The Last Decade

Tilo Senger

10 papers receiving 349 citations

Peers

Tilo Senger
Wai-Ping Woo Australia
Jason P. Laliberte United States
Andrew W. Hudacek United States
Steve Harris United Kingdom
Lautaro G. Perez United States
Henry Z. Markus United States
Rongyu Zeng United States
Wai-Ping Woo Australia
Tilo Senger
Citations per year, relative to Tilo Senger Tilo Senger (= 1×) peers Wai-Ping Woo

Countries citing papers authored by Tilo Senger

Since Specialization
Citations

This map shows the geographic impact of Tilo Senger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilo Senger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilo Senger more than expected).

Fields of papers citing papers by Tilo Senger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilo Senger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilo Senger. The network helps show where Tilo Senger may publish in the future.

Co-authorship network of co-authors of Tilo Senger

This figure shows the co-authorship network connecting the top 25 collaborators of Tilo Senger. A scholar is included among the top collaborators of Tilo Senger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilo Senger. Tilo Senger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Handisurya, Alessandra, Christina Schellenbacher, Andrea Haitel, Tilo Senger, & Reinhard Kirnbauer. (2016). Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids. British Journal of Cancer. 114(4). 409–416. 37 indexed citations
2.
Almajhdi, Fahad N., Tilo Senger, Haitham M. Amer, Lutz Gissmann, & Peter Öhlschläger. (2014). Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling). PLoS ONE. 9(11). e113461–e113461. 15 indexed citations
3.
Gaiser, Maria Rita, Sonja Textor, Tilo Senger, et al.. (2014). Evaluation of specific humoral and cellular immune responses against the major capsid L1 protein of cutaneous wart-associated alpha-Papillomaviruses in solid organ transplant recipients. Journal of Dermatological Science. 77(1). 37–45. 7 indexed citations
4.
Weber, Kela P., et al.. (2010). Influence of the Microbial Community in the Treatment of Acidic Iron-Rich Water in Aerobic Wetland Mesocosms. Bioremediation Journal. 14(1). 28–37. 10 indexed citations
5.
Senger, Tilo, et al.. (2009). Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity. Vaccine. 27(10). 1511–1522. 65 indexed citations
6.
Senger, Tilo, Sonja Textor, Corinna Klein, et al.. (2009). Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs. Vaccine. 28(6). 1583–1593. 22 indexed citations
7.
Senger, Tilo, Norbert Mücke, Corinna Klein, et al.. (2009). Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity. Journal of Virology. 83(15). 7690–7705. 53 indexed citations
8.
Senger, Tilo, et al.. (2009). Enhanced papillomavirus-like particle production in insect cells. Virology. 388(2). 344–353. 45 indexed citations
9.
Senger, Tilo, et al.. (2009). Identification of B-Cell Epitopes on Virus-Like Particles of Cutaneous Alpha-Human Papillomaviruses. Journal of Virology. 83(24). 12692–12701. 15 indexed citations
10.
Schröfelbauer, Bärbel, Tilo Senger, Gerard Manning, & Nathaniel R. Landau. (2006). Mutational Alteration of Human Immunodeficiency Virus Type 1 Vif Allows for Functional Interaction with Nonhuman Primate APOBEC3G. Journal of Virology. 80(12). 5984–5991. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026